FDA inspection

C2C Development, LLC: FDA inspection ending Apr 10, 2018

FDA inspection 1048098 · Voluntary Action Indicated (VAI) · Melbourne, FL

Key facts

Inspection ID 1048098
Firm C2C Development, LLC
FEI number 3011193444
Address 1135 W Nasa Blvd Ste 500
City Melbourne
State FL
ZIP 32901
Country United States
Fiscal year 2018
Inspection end date Apr 10, 2018
Classification Voluntary Action Indicated (VAI)
Project area Postmarket Assurance: Devices
Product type Devices

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections